(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
New science points to 4 distinct types of autism - 2Ageless Tastefulness: An Outline of Valuable Gemstones and Adornments
- 3Bolsonaro says hallucinatory effects of meds made him tamper with ankle tag
- 4Must-See Public Parks from Around the Globe
- 56 Web-based Course Stages for Successful Learning and Educating
- ‘And then we saw the little head.’ Scientists witness rare sperm whale birth
- The most effective method to Apply Antiquated Ways of thinking in Current Brain science Practices
- It's time for Artemis II to break Apollo 13's distance record. What to know about the moon flyby
- Dave Coulier reveals he has tongue cancer, his 2nd diagnosis in a year, after beating non-Hodgkin lymphoma
- Photos of amputees in Gaza, struggling to survive after losing limbs to Israeli airstrikes
- Argentina joins NASA’s moon return with microsatellite testing GPS beyond Earth
- Ancient meditation practices find new life in modern religious communities across America
- Was This Driver Simply Having Some good times Or Behaving Like An Ass?
- Man threatens attack on German high-speed train, injures several
